[Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].
Vigabatrin (VGB) is a new antiepileptic drug, that acts by the irreversible inhibition of gamma-aminobutyric acid (GABA) aminotransferase. Chronic antiepileptic therapy with VGB is associated with visual field defects and electrophysiological changes.